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Availability of essential diagnostics in ten low-income and 
middle-income countries: results from national health 
facility surveys
Harika Yadav, Devanshi Shah, Shahin Sayed, Susan Horton, Lee F Schroeder
Summary
Background Pathology and laboratory medicine diagnostics and diagnostic imaging are crucial to achieving universal 
health coverage. We analysed Service Provision Assessments (SPAs) from ten low-income and middle-income 
countries to benchmark diagnostic availability.
Methods Diagnostic availabilities were determined for Bangladesh, Haiti, Malawi, Namibia, Nepal, Kenya, Rwanda, 
Senegal, Tanzania, and Uganda, with multiple timepoints for Haiti, Kenya, Senegal, and Tanzania. A smaller set of 
diagnostics were included in the analysis for primary care facilities compared with those expected at hospitals, with 
16 evaluated in total. Surveys spanned 2004–18, including 8512 surveyed facilities. Country-specific facility types were 
mapped to basic primary care, advanced primary care, or hospital tiers. We calculated percentages of facilities offering 
each diagnostic, accounting for facility weights, stratifying by tier, and for some analyses, region. The tier-level 
estimate of diagnostic availability was defined as the median of all diagnostic-specific availabilities at each tier, and 
country-level estimates were the median of all diagnostic-specific availabilities of each of the tiers. Associations of 
country-level diagnostic availability with country income as well as (within-country) region-level availability with 
region-specific population densities were determined by multivariable linear regression, controlling for appropriate 
covariates including tier. 
Findings Median availability of diagnostics was 19·1% in basic primary care facilities, 49·2% in advanced primary care 
facilities, and 68·4% in hospitals. Availability varied considerably between diagnostics, ranging from 1·2% 
(ultrasound) to 76·7% (malaria) in primary care (basic and advanced) and from 6·1% (CT scan) to 91·6% (malaria) in 
hospitals. Availability also varied between countries, from 14·9% (Bangladesh) to 89·6% (Namibia). Availability 
correlated positively with log(income) at both primary care tiers but not the hospital tier, and positively with region-
specific population density at the basic primary care tier only.
Interpretation Major gaps in diagnostic availability exist in many low-income and middle-income countries, 
particularly in primary care facilities. These results can serve as a benchmark to gauge progress towards implementing 
guidelines such as the WHO Essential Diagnostics List and Priority Medical Devices initiatives.
Funding Bill & Melinda Gates Foundation.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license. 
Introduction
To benefit from essential medicines, a patient must have 
an accurate diagnosis. Without access to diagnostics, 
including pathology and laboratory medicine (PALM) 
diagnostics and diagnostic imaging, patient management 
relies on syndromic diagnosis and empiric treatment.1,2 A 
recent series of Lancet reviews have described the lack of 
access to diagnostics and the roadmap to improvement.3–5
While there has been a significant improvement in 
diagnostic support for HIV/AIDS, tuberculosis, and 
malaria in low-income and middle-income countries 
(LMICs) over the past decades, significant gaps persist in 
availability and quality, even for diseases of public health 
priority.6–9
Although several studies have documented diagnostic 
availability within different countries and settings,10–13 few 
have used a common methodology to analyse diagnostic 
availability between countries. One such study14 extracted 
data from the Survey Provision Assessment (SPA) in the 
Demographic and Health Surveys (DHS) in ten countries 
and assessed 50 items that the WHO considers essential 
for providing health care, including eight diagnostic 
tests. The authors found only 2% of facilities provided all 
these essential diagnostics.14 However, a limitation of this 
study was that only eight laboratory diagnostic tests were 
included (with no diagnostic imaging) and that analysis 
did not stratify by specific test.
We aimed to analyse SPA surveys to comprehensively 
detail essential diagnostic capacity. We assessed availability 
by health facility tier, by region within-country, and by 
associating availability to country incomes, population 
densities, and trends over time for 16 PALM and imaging 
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diagnostics. These findings can inform ongoing policy 
efforts to improve diagnostic services in LMICs.
Methods
Study design
In this study, we extracted health facility data from the 
SPA database of USAID, which provides an evaluation 
of health services capacity in countries, including clinical 
laboratory testing and diagnostic imaging. The number 
of facilities in SPA surveys is powered to be representative 
of facility type and within-country region (eg, site visits 
to 10% of all facilities in the country, with weighting 
factors provided for national estimation), although in 
some cases all facilities are surveyed (Haiti, Malawi, 
Namibia, and Rwanda). Facility types describe the level 
of care (eg, from basic primary care facilities such as 
health posts and pharmacies to tertiary care hospitals). 
Regions typically represent level one administrative 
political boundaries. SPA surveys include facilities of 
public and non-public ownership and are cross-sectional. 
This study used publicly available data and was not 
subject to approval by an ethics committee.
Procedures
Questions about diagnostics in SPA surveys typically 
included the following: “Is the test reported to be done at 
the site?”; “is all the equipment used for the test available 
and observed by a surveyor?”; and “is all the testing 
equipment in working condition?”. In this study, a 
diagnostic was considered available at the facility if the 
answer to each question was affirmative for all three 
questions, or if records of specimen transport of samples 
to higher tiers were available. A set of 16 diagnostics 
(including all three available imaging modalities [eg, 
x-ray, ultrasound, and CT]) were included in this study, 
chosen by expert opinion of the coauthors, while each 
PALM diagnostic is on the WHO Essential Diagnostics 
List v3 (EDL).15 The EDL recommends different tests for 
different levels of capacity in a health system. We 
therefore chose different sets of diagnostics to be expected 
at different tiers. This assignment was informed by the 
EDL, which lists tests for facilities with and without 
laboratories, as well as the WHO recommendations for a 
Positive Pregnancy Experience, which lists antenatal care 
diagnostics in primary care.16 Therefore, at primary care, 
we assigned diagnostics for HIV, malaria, urine glucose 
and protein, urine pregnancy, syphilis, microscopy, 
haemoglobin, and glucose by glucometer, as well as 
ultrasound. At the hospital level, we additionally assigned 
Gram stain, chemistry analysers, haematology analysers, 
tuberculosis, x-ray, and CT (appendix p 4). Glucometers 
and haemoglobin were removed from the hospital level 
list because these tests are included on chemistry and 
haematology analysers. 
At the time of data extraction (February, 2020), DHS 
SPA surveys were available for ten countries: Bangladesh, 
Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, 
Tanzania, and Uganda. Abbreviated surveys (eg, HIV 
SPA) were excluded except for the Maternal 
and Child Health and HIV SPA performed in Kenya 
in 2004, which allowed an earlier timepoint comparison. 
Overall, two surveys from different timepoints were 
included for four of these countries: Haiti, Kenya, 
Senegal, and Tanzania. Surveys spanned 2004–18 and 
Research in context
Evidence before this study
There has been no previous study focusing on general 
diagnostic availability across multiple countries using a 
nationally representative survey tool. The Service Provision 
Assessment is a health facility survey providing an overview of 
a country’s health service readiness and includes questions on 
laboratory and radiological diagnostic capacity. One report 
summarising SPA findings across all components of health care 
included a brief assessment of laboratory capacity, finding that 
only 2% of facilities across ten countries adequately offered all 
eight tests selected for analysis in the study, but it did not 
stratify availability by test and did not include radiological 
examinations. With the establishment of the WHO Essential 
Diagnostics List in 2018 and growing international consensus 
that improved laboratory and radiological investment is crucial, 
there is a need to establish a baseline against which future 
investments in diagnostic capacity can be measured.
Added value of this study
This study provides an in-depth evaluation of the availability 
for 16 laboratory and radiological diagnostics across 
ten low-income and middle-income countries. We found 
diagnostic availability in general to be limited, but that it varied 
greatly by the type of diagnostic, the tier of the facility within 
the health system, and country. We also found that in primary 
care, but not hospitals, availability tended to be lower in 
countries with lower per capita income and in regions with 
lower population density within each country.
Implications of all the available evidence
The study finds the overall availability of essential diagnostics 
to be lacking at the time of the surveys in many low-income 
and middle-income countries, but that there is relatively higher 
capacity that exists for some diagnostics, particularly at the 
hospital level. Therefore, policies should aim to improve 
diagnostic capacity in general but also to ensure a focus on 
primary care. This analysis can act as a baseline against which 
the impact of future investments in diagnostic services can 
be measured.
See Online for appendix
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included 8512 facilities across all surveys. These countries 
represent a range of LMIC economies of varying 
geographical size and development status. SPA surveys 
are typically recoded to facilitate comparison by year and 
country and there have been several versions of recoding 
over the years. Minor adjustments in our analysis allowed 
for comparison between recode versions. The survey in 
Congo from 2018 was excluded because it was not 
recoded. We recoded the Senegal 2017 survey to facilitate 
comparison to the Senegal 2012 survey.
Each SPA survey publishes a report and includes 
estimates of diagnostic availability. Countries might 
choose to calculate availability in different ways. 
For example, one country might choose to calculate 
availability of tuberculosis sputum testing as a 
percentage of all health facilities, while another might 
calculate as a percentage of all health facilities that offer 
tuberculosis services. To facilitate comparison between 
countries, we recalculated each diagnostic’s availability 
using the same criteria for every country (appendix p 4), 
even if these calculations did not match each individual 
country’s published report. When data were missing for 
a given question (eg, “NA” in data fields), we assumed 
the test was not available as the relevant service was not 
offered, consistent with a previous study of these same 
data (where 36% of diagnostic data fields were “NA”).14 
Facilities with zero weighting were excluded (210 of 
8512 facilities; no explanations were provided in SPA 
datasets). When considering availability of a diagnostic, 
any test format was accepted including specimen 
transport (provided logs were observed). For example, 
tuberculosis testing would be satisfied by on-site acid-
fast bacteria sputum microscopy or nucleic acid testing 
(or specimen transport for either).
Each country used similar but unique health system 
tiers. To compare results between countries, country-
specific tiers were mapped onto one of three generalised 
tiers: basic primary care, advanced primary care, or 
hospital (see appendix p 5 for tier assignments). Where 
facility descriptions were available, primary care 
facilities with trained staff but no medical doctors or 
nurses were considered to be in the basic primary care 
tier, and those with doctors or nurses were considered 
to be in the advanced primary care tier. As an example, 
in Tanzania, health posts and dispensaries were merged 
into the basic primary care tier, health centres 
represented the advanced primary care tier, while all 
hospital types were merged into the hospital tier. For 
Senegal, we excluded Case de Santé facilities as they are 
an extension of basic primary care into communities 
with care delivered by community health workers, and 
the SPA evaluation of diagnostics for these facilities 
was limited to malaria.
Statistical analysis
Percentages of facilities offering each diagnostic test were 
calculated from SPA data, accounting for facility weights, 
stratifying by tier, and for some analyses, region. The tier-
level estimate of diagnostic availability was defined as the 
median of all diagnostic-specific (eg, haemoglobin or 
ultrasound) availabilities at each tier, and country-level 
estimates were the median of all diagnostic-specific 
availabilities at each of the tiers. All references to changes 
in availability refer to absolute changes, such that a 
5 percentage points increase from 50% would be 55%. 
Some diagnostics were not in some surveys and were 
excluded from the calculations (eg, glucose meters in 
Kenya and HIV testing in Bangladesh). Where multiple 
laboratories were present in a single facility, diagnostic 
capacity in any one laboratory was sufficient to consider 
the diagnostic available. Median diagnostic availability 
in different within-country regions were evaluated 
with interquartile ranges (IQR), quartile coefficients of 
dispersion, and outlier detection. Outliers were defined 
with availabilities beyond 3 median absolute deviations 
(MAD; the median of the absolute value of each point’s 
deviation from the median) from the within-country 
median.17 MAD was calculated using the mad() command 
in R using a scaling factor of 1·4826 so that, for normally 
distributed data, MAD equals standard deviation. 
Associations of country-level diagnostic availability with 
country income (World Bank gross-domestic product per 
capita at constant prices of 2019) and (within-country) 
region-level availability with region-specific population 
densities were determined by multivariable linear regres-
sion, controlling for appropriate covariates including tier. 
To avoid extreme values and to facilitate comparison 
between countries, incomes were log10-transformed and 
region-specific population densities were centred and 
scaled within-country. Change of availability associated 
with a 10% change in income was calculated as 
log10(1 + 0·1) × (regression coefficient). Only the most 
recent survey for each country was included for all 
analyses other than comparisons of availability over 
successive surveys within the same country. All analyses 
were performed in R statistical environment (v.3.6.3).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report.
Results
Diagnostic availability varied considerably by diagnostic 
and by tier (figure 1). Median availability of diagnostics 
expected to be found at the respective tiers increased 
at higher tiers in the health system: basic primary 
care (19·1%, IQR 6·4–36·7), advanced primary care 
(49·2%, 18·1–75·0), and hospital (68·4%, 51·1–84·6). 
The most available diagnostics, regardless of tier, 
included those for HIV, malaria, urine protein, urine 
glucose, urine pregnancy, and, at the advanced primary 
care and hospital tiers, those for microscopy and 
syphilis (appendix p 8). Tests available in instrument-free 
For more on the World Bank 
GDP see https://data.worldbank.
org/indicator/NY.GDP.MKTP.CD
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point-of-care formats (eg, malaria, HIV, urine protein 
and glucose, pregnancy, and syphilis) showed more 
availability whereas diagnostic imaging was among the 
least available within each tier. Availability based 
on specimen transport was minimal and only for 
some diagnostics: tuberculosis (6·6% median availability 
between all country-tier availabilities), HIV PCR (3·5%), 
HIV ELISA (2·7%), basic chemistries (1·6%), Gram 
stain (1·1%), urinalysis (1·0%), malaria (0·8%), HIV 
western blot (0·7%), and HIV rapid (0·3%).
Across tiers, Namibia had the highest country-level 
availability of PALM and imaging diagnostics (89·6%), 
followed by Senegal (62·2%), Tanzania (59·8%), 
Haiti (57·6%), Kenya (55·5%), Rwanda (49·0%), 
Nepal (34·9%), Uganda (34·4%), Malawi (31·6%), and 
Bangladesh (14·9%; figure 1). However, between-country 
rankings of tier-level availability varied by tier, with 
Senegal ranking second highest in availability in both 
basic and advanced primary tiers but lowest in availability 
at the hospital tier. By contrast, Nepal ranked lowest in 
basic primary and third lowest in advanced primary, while 
ranking third highest in the hospital tier (appendix p 9). 
Country-level availabilities were correlated (spearman’s 
rank correlation coefficient) between basic and advanced 
primary care tiers (ρ=0·92), but not between other tier-
pairs (appendix p 2).
Multivariable linear regression of median availability 
against log10(income), tier, year of survey, and the 
interaction of log10(income) and tier, showed a positive 
effect of log10(income) at both primary care tiers 
compared with hospital tier (figure 2 and appendix 
p 10). For each increase in income of 10 percentage 
points, there was an associated absolute increase of 
2·4 percentage points availability at the basic primary 
care tier and of 2·2 percentage points availability at the 
advanced primary care tier.
In evaluating equity of access, variation of diagnostic 
availability within-country was calculated through analysis 
of region-specific availabilities of diagnostic methods at 
different tiers (figure 3). Most countries had at least one 
outlier region when summing up outliers across tiers: 
Tanzania (six outliers), Namibia (four outliers), Kenya 
(three outliers), Senegal (three outliers), Uganda (two 
outliers), Nepal (one outlier), Malawi (one outlier; see 
appendix p 1). At the basic primary care tier there were 
four outliers overall (all with greater availability). At the 
advanced primary care tier there were five outliers overall 
(three with greater availability). At the hospital tier there 
were 11 outliers overall (none with greater availability). 
No outlier regions were found in Haiti, Rwanda, or 
Bangladesh. IQRs of regional availability within country 
and tier spanned from 0% to 30·9%. The median IQR for 
all countries was greatest at the advanced primary care 
tier (14·2%), and slightly lower at the basic primary 
care (9·9%) and hospital (10·6%) tiers. Only one country, 
Haiti, showed both a relatively high IQR and quartile 
coefficient of dispersion (appendix p 12). Multivariable 
linear regression including normalised population 
density, tier, country, and the interaction of tier and 
population density found region-specific population 
density to be positively associated with availability of 
diagnostics at the basic primary care tier as compared 
with the hospital tier (figure 4, appendix p 12).
Four countries were evaluated for diagnostic availability 
over time (Haiti, Kenya, Senegal, and Tanzania). There 
was an increase in country-level diagnostic availability in 
Figure 1: Availability of diagnostics by tier and country
The heat map provides information on the proportion of facilities offering the diagnostic. Percentages in parentheses after each country name is the median 
diagnostic availability of all cells in each row. For countries with more than one survey, only the most recent was included. Countries are ranked in descending order of 
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all countries, ranging from 3·7 to 14·9 percentage points 
(table; appendix p 3). For each country and each tier, 
there was always a positive change, except Tanzania and 
Kenya at the hospital tier, which showed a decrease of 
15·1 and 3·5 percentage points, respectively. Otherwise, 
diagnostic availability increased between 2·8 and 
50·4 percentage points across health facility tiers, with 
greatest improvements seen in the basic primary and 
advanced primary care tiers (table). Most tests showed an 
increase in availability at the basic primary care tier: 
100% of tests (Haiti), 100% (Kenya), 80% (Senegal), 
88% (Tanzania). Similarly, most tests showed an increase 
in availability at the advanced primary care tier: 
90% (Haiti), 100% (Kenya), 80% (Senegal), and 
88% (Tanzania). Results were mixed at the hospital tier, 
with increases for 100% (Haiti), 55% (Kenya), 57% 
(Senegal), and 25% (Tanzania) of tests.
Discussion
This study of ten LMICs has found that most essential 
diagnostic services in the majority of countries 
undergoing the Service Provision Assessment were very 
limited, when comparing with WHO standards such as 
the Essential Diagnostics List (EDL) and the Positive 
Pregnancy Experience guidelines.15,16 Even for the most 
available tests, such as HIV testing, median availability 
was under 40% in the basic primary care tier. At the 
hospital tier, many essential diagnostic tests had an 
availability of 46–62%, including basic chemistry tests, 
automatic complete blood count, Gram stain, tubercu-
losis testing, x-ray, and ultrasound. This is consistent 
with other landscaping studies that demonstrate low 
availability of essential diagnostics as listed in the WHO’s 
Essential Diagnostics List.10–13,18
This pattern of availability is not surprising. Enormous 
international funding has been devoted to HIV and 
malaria programmes, which have the most readily 
Figure 3: Variation of diagnostic availability among regions of each country, by tiers
In this dot plot, the IQR and QCD of region-specific availabilities are calculated for each country and tier. Outliers are 
depicted with asterisks and determined as described in the methods section. QCD=quartile coefficient of dispersion.
Figure 2: Availability by GDP per capita
Plot of marginal effects showing the association between median country-
level diagnostic availability by tier with income, after adjusting with a 
covariate for year of survey. The interaction of income and tier had p values of 
0·044 for basic primary care and 0·057 for advanced primary care tiers 
(appendix p 10). The interaction between tier and income is evidenced by 
more sloped lines at primary care tiers as compared with the hospital tier. 
Separate linear regressions performed independently for each tier, with Year as 
covariate, produced significant coefficients for basic primary care (p=0·00155), 
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available diagnostics at primary health-care level. Other 
diagnostics found to be most available in this study are 
available in inexpensive, point-of-care formats such as 
dipsticks and lateral flow assays. PALM and imaging 
diagnostics outside of vertical programmes that require 
investment for equipment as well as staffing were found 
to have lower availability.
Median availability of diagnostics increased with 
increasing health facility tier: basic primary care (19·1%), 
advanced primary care (49·2%), and hospital (68·4%). In 
many LMICs, primary health care usually comprises 
health posts and dis pensaries that serve a smaller 
population, are located rurally, are staffed by personnel 
with limited training, and most often do not have 
laboratories. These factors all contribute to the lack of 
diagnostic capacity at lower health system tiers. 
Furthermore, budget lines in Ministries of Health often 
do not provide protected funding for diagnostics.19 
According to the Maputo Declaration of 2008, laboratory 
networks should be developed such that lower tier 
facilities can send laboratory specimens to higher tier 
facilities. Our study gave credit for so-called send-out 
testing to higher tier facilities but specimen referral was 
rarely offered. We therefore conclude that laboratory 
networks were largely not functional at the time of 
surveys. Although teleradiology does offer the ability for 
remote reading by radiologists, there is a critical lack of 
the basic imaging equipment required.
Generally, availability ranking between countries 
persisted when each tier was analysed separately. 
However, there were exceptions as Senegal had the 
second highest availability at the primary tiers but lowest 
availability at the hospital tier, indicating that more 
resources were distributed to the primary sector than to 
higher sectors. This correlates with findings in another 
study that showed that, in accordance with the national 
referral policy of Senegal, efforts were made to increase 
basic health services in the public sector.20 Multiple 
public-private partnerships were developed to extend the 
range of services that could be offered within the public 
health system due to the Senegalese National Financing 
Strategy for Universal Health Coverage. By contrast, 
Nepal shows the opposite pattern. It had the second 
highest availability of diagnostics at the hospital tier but 
lowest availability at the primary levels. This pattern 
might be a result of the Nepalese health system being 
driven by multiple donor organisations mainly developing 
disease-driven vertical programmes, while capacity 
building with generalised medical equipment has not 
been prioritised within the government-run primary 
health sector.21 This lack of priority to the primary health-
care sector might explain why populations largely 
circumvent closer facilities favouring higher levels of care 
even for essential services such as antenatal care and 
child birth .
Namibia showed the highest availability across all 
tiers, perhaps because of its high per capita GDP but 
also because of the investment in diagnostics and 
establishment of the Namibia Institute of Pathology (NIP), 
which acts as a reference laboratory system for state health 
services. The NIP was established as a public enterprise in 
2000, taking control of 23 laboratories from the Ministry 
of Health and Social Services at a time when these facilities 
were facing staffing and infrastructural challenges.22 By 
contrast, Bangladesh, which has the third highest per 








Haiti (2018/2013) 6·9 pp 10·2 pp 13·9 pp 8·8 pp
Kenya (2010/2004) 5·5 pp 30·8 pp –3·5 pp 14·9 pp
Senegal (2017/2012) 50·4 pp 7·4 pp 2·8 pp 10·6 pp
Tanzania (2014/2006) 6·0 pp 7·8 pp –15·1 pp 3·7 pp
pp=percentage point.
Table: Change in median overall diagnostic availability over time by tier, 
by country
Figure 4: Region-specific availability by regional population density, by tiers
Plot of marginal effects showing the association between region-level 
diagnostic availability and population density by tier. The interaction of 
population density with tier is shown by a more sloped line at the basic primary 
care tier than other tiers. Since the regional population density is Z score 
transformed within-country, the regression coefficient of 5·4 for the interaction 
term population density:basic primary care means a Z score population density 
shift of 1 is associated with an increase of 5·4 percentage points in availability at 
the basic primary care tier (eg, shift from 50·0% to 55·4%). See appendix p 16.
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For more on the World Bank 





For more on Kenya’s Vision 
2030 see http://vision2030.go.
ke/social-pillar/#66
in availability in each tier. This low ranking might be due 
to the fact that domestic general government health 
expenditure is only 17% of current total health expenditure 
(and the third lowest among the study countries, according 
to the World Bank). Nonetheless, when regressing against 
income, avail ability of diagnostics across all countries 
were positively associated with income, although only in 
primary care. One interpretation of this difference 
for primary care is that only in countries with greater 
income do investments in diagnostics continue down 
from tertiary to primary care. Critically, the WHO has 
emphasised the importance of improving primary 
care in achieving universal health coverage,23 and that 
improvement includes appropriate diagnostics.
Based on a relatively large regional IQR and quartile 
coefficient of dispersion, inequality of diagnostic 
availability was greatest for Haiti’s basic primary care 
tier, possibly because of inequitable or incomplete 
reconstruction efforts after hurricane Matthew devastated 
much health-care infrastructure 2 years before the survey. 
There were 20 outlier regions identified across all ten 
countries and tiers (of 334 region-tier pairs in total). Six of 
seven outliers with higher availability were from regions 
with population densities above the 75th percentile for 
the country. By contrast, population density did not 
appear to predict outlying regions with low availability, as 
only three such regions had population density below the 
country-specific 25th percentile (appendix p 11). In Kenya 
for example, both Nairobi (capital city) and northeastern 
regions were outliers with low availability of diagnostics 
at the advanced primary care level. In urban centres 
like Nairobi, patients might prefer hospitals rather than 
primary health centres because they know there are more 
comprehensive services available at the hospital. Most of 
the diagnostics in Kenyan urban cities such as Nairobi are 
offered in a vibrant private sector both in hospitals and in 
stand-alone PALM and diagnostic imaging centres while 
investment in the public health-care sector, especially in 
diagnostics, is not prioritised. Furthermore, as part of 
Kenya’s Vision 2030, the plan to improve health care was 
to systematically reduce the government’s role in service 
provision while encouraging private sector investments. 
By contrast, the northeastern region of Kenya is sparely 
populated and historically marginalised24 thus leading 
to a regional imbalance in economic, social, and political 
development. Multivariable regression found region-
specific availability to be positively associated with 
population density, but only in the basic primary care 
tier. This difference might again be due to diagnostics 
investment occurring first in higher tier facilities and 
only last in primary care, with this effect being amplified 
in low-population regions likely to be less wealthy and 
more remote.
As for trends over time within country, our study 
found that each of the four countries with multiple 
timepoints indeed modestly improved availability from 
one survey to the next, consistent with real increases in 
per capita GDP for each country between surveys. While 
Haiti’s per capita GDP growth was small, improvement 
might have been due to external assistance in the 
rebuilding effort after the 2016 hurricane. The greatest 
increases were in basic primary care (ranging from 
5·5 to 50·4 percentage points) and advanced primary 
care (from 7·4 to 30·8 percentage points) compared 
with hospitals (from –15·1 to 13·9 percentage points). 
Notably, Senegal basic primary care availability increased 
dramatically by 50·4 percentage points, consistent with 
health investments discussed above, though the mean 
of diagnostic-specific availabilities only increased by 
17·6 percentage points.
There were several limitations to this study. This study 
only evaluated availability in facilities, not necessarily 
accessibility for a population. If a patient does not have 
access to facilities, then they would not have access to 
the diagnostics. As an example, Namibia has poor 
accessibility to facilities (in terms of access within 2 h for 
the population),25 but high availability of diagnostics at 
the facilities. This study also did not evaluate the number 
of tests performed or whether skilled staff were available, 
only that there was functioning equipment. It is possible 
that due to affordability or preferences from the 
provider or patient, these diagnostic services were not 
appropriately utilised. Also, SPA surveys are not typically 
conducted with high frequency, thus we relied on data 
ranging from 2004 to 2018. Importantly, there have been 
successful diagnostics capacity initiatives after surveys. 
As an example, Uganda has implemented a hub-and-
spoke referral system to the Uganda National Public 
Health Laboratory Service (UNPHLS), which provides 
country-wide testing for multiple conditions, including 
HIV, tuberculosis, and epidemic-prone diseases, as well 
as haematology and chemistry tests.26 The effect of that 
network was not captured in the 2007 SPA survey. 
However, the SPA survey can be used to benchmark the 
improvement of the UNPHLS initiative if an additional 
survey were to be conducted. Such studies should occur 
as they do with respect to medicines. Medicines from 
the WHO Essential Medicines List are routinely surveyed 
for availability and cost globally, as per resolution of 
WHO Member States at the 54th World Health Assembly 
in 2001, calling for the development of “systems for 
voluntary monitoring drug prices and reporting global 
drug prices” (Resolution WHA 54·11).27
The DHS Service Provision Assessments allow a unique 
opportunity to landscape diagnostic availability across 
multiple LMICs, using a representative survey conducted 
similarly in each country. When benchmarking to the 
WHO Essential Diagnostics List and the WHO Positive 
Pregnancy Experience guidelines, this study has shown 
there remain large gaps in availability at each tier in health 
systems, with particular deficits in primary care. However, 
we hope this study will help establish a baseline against 
which progress in diagnostics delivery can be measured as 
countries adopt national-level essential diagnostics lists. 
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Successful delivery of universal health coverage must 
include essential diagnostic availability throughout health-
care systems. This  availability must be accompanied 
by accessibility for patients to these diagnostics, as well 
as high quality and timely results. These efforts will 
require financing, strengthening of infrastructure, human 
resource development, and national policies to establish 
evidence-based use of diagnostics to ensure the greatest 
impact on patient care.
Contributors
LFS contributed to the conceptualisation, study design, data analysis, 
data interpretation, figures, writing, and review of the manuscript. 
HY contributed to the study design, data analysis, data interpretation, 
writing, and review of the manuscript. SS contributed to data 
interpretation, manuscript review, and editing. LFS and HY had access to 
and verified the data. DS contributed to the data analysis and manuscript 
review. SH contributed to the conceptualisation, data interpretation, 
writing, review of the manuscript, and funding acquisition. 
Declaration of interests
We declare no competing interests.
Data sharing
Raw data from this study are available at no cost from The DHS 
Program of USAID.
References
1 Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory 
medicine in Africa: a barrier to effective health care. Clin Infect Dis 
2006; 42: 377–82.
2 Carter JY, Lema OE, Wangai MW, Munafu CG, Rees PH, 
Nyamongo JA. Laboratory testing improves diagnosis and 
treatment outcomes in primary health care facilities. Afr J Lab Med 
2012; 1: 8.
3 Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K. 
Access to pathology and laboratory medicine services: a crucial gap. 
Lancet 2018; 391: 1927–38.
4 Horton S, Sullivan R, Flanigan J, et al. Delivering modern, high-
quality, affordable pathology and laboratory medicine to low-income 
and middle-income countries: a call to action. Lancet 2018; 
391: 1953–64.
5 Sayed S, Cherniak W, Lawler M, et al. Improving pathology and 
laboratory medicine in low-income and middle-income countries: 
roadmap to solutions. Lancet 2018; 391: 1939–52.
6 WHO. World Malaria Report. 2020. https://www.who.int/
publications/i/item/9789240015791 (accessed March 2, 2021).
7 WHO. Progress report on HIV, viral hepatitis and sexually 
transmitted infections, 2019. Vol 1–48. Geneva, Switzerland: World 
Health Organization, 2019.
8 WHO. Global Tuberculosis Report. Geneva, Switzerland: World 
Health Organization, 2020. http://library1.nida.ac.th/termpaper6/
sd/2554/19755.pdf (accessed March 2, 2021).
9 Schroeder LF, Amukele T. Medical laboratories in sub-Saharan 
Africa that meet international quality standards. Am J Clin Pathol 
2014; 141: 791–95.
10 Ward CL, Guo MZ, Amukele TK, Abdul-Karim A, Schroeder LF. 
Availability and prices of WHO essential diagnostics in laboratories 
in west Africa: a landscape survey of diagnostic testing in northern 
Ghana. J Appl Lab Med 2021; 6: 51–62.
11 Shumbej T, Menu S, Gebru T, et al. Essential in-vitro laboratory 
diagnostic services provision in accordance with the WHO 
standards in Guragae zone primary health care unit level, South 
Ethiopia. Trop Dis Travel Med Vaccines 2020; 6: 4.
12 Kohli M, Walia K, Mazumdar S, Boehme CC, Katz Z, Pai M. 
Availability of essential diagnostics in primary care in India. 
Lancet Infect Dis 2018; 18: 1064–65.
13 Sánchez-Sánchez J, Alarcón-Loayza J, Villa-Castillo L, et al. 
Availability of essential diagnostics at primary care public clinics in 
Peru. Microbes Infect 2021; 23: 104761.
14 Leslie HH, Spiegelman D, Zhou X, Kruk ME. Service readiness of 
health facilities in Bangladesh, Haiti, Kenya, Malawi, Namibia, 
Nepal, Rwanda, Senegal, Uganda and the United Republic of 
Tanzania. Bull World Health Organ 2017; 95: 738–48.
15 WHO. The selection and use of essential in vitro diagnostics v3. 
World Health Organization technical report series. Geneva, 
Switzerland: World Health Organization, 2021.
16 WHO. WHO recommendations on antenatal care for a positive 
pregnancy experience. Geneva, Switzerland: World Health 
Organization, 2016.
17 Pearson RK. Outliers in process modeling and identification. 
IEEE Trans Control Syst Technol 2002; 10: 55–63.
18 Schroeder LF, Elbireer A, Jackson JB, Amukele TK. Laboratory 
diagnostics market in east Africa: a survey of test types, test 
availability, and test prices in Kampala, Uganda. PLoS One 2015; 
10: e0134578.
19 Ondoa P, van der Broek A, Jansen C, de Bruijn H, Schultsz C. 
National laboratory policies and plans in sub-Saharan African 
countries: gaps and opportunities. Afr J Lab Med 2017; 6: 578.
20 Paul E, Ndiaye Y, Sall FL, Fecher F, Porignon D. An assessment 
of the core capacities of the Senegalese health system to 
deliver Universal Health Coverage. Health Policy Open 2020; 
1: 100012.
21 Sharma J, Aryal A, Thapa GK. Envisioning a high-quality health 
system in Nepal: if not now, when? Lancet Glob Health 2018; 
6: e1146–48.




23 WHO. Primary Health Care on the Road to Universal Health 
Coverage. Geneva: Switzerland, World Health Organization, 2019.
24 Friedrich-Ebert-Stiftung. Regional Disparities and Marginalisation 
in Kenya, vol 39. Childhood Education. Nairobi, Kenya: Elite 
PrePress Ltd, 2012.
25 Iyer HS, Flanigan J, Wolf NG, et al. Geospatial evaluation of trade-
offs between equity in physical access to healthcare and health 
systems efficiency. BMJ Glob Health 2020; 5: e003493.
26 Fonjungo PN, Alemnji GA, Kebede Y, et al. Combatting global 
infectious diseases: a network effect of specimen referral systems. 
Clin Infect Dis 2017; 64: 796–803.
27 WHO. WHO/Health Action International project on medicine 
prices and availability. https://www.who.int/teams/health-
product-and-policy-standards/medicines-selection-ip-and-
affordability/who-hai-project-medicine-prices-and-availability 
(accessed Sept 23, 2021).
For the DHS Program of USAID 
see https://dhsprogram.com/
data/
Downloaded for Anonymous User (n/a) at The Aga Khan University Hospital Nairobi from ClinicalKey.com by Elsevier on 
November 09, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
